首页> 外文期刊>Patient education and counseling >Diabetes Medication Assistance Service: the pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia.
【24h】

Diabetes Medication Assistance Service: the pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia.

机译:糖尿病药物辅助服务:在澳大利亚,药剂师在支持患者自我管理2型糖尿病(T2DM)方面的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To evaluate the capacity and effectiveness of trained community pharmacists in delivering the Diabetes Medication Assistance Service (DMAS) via (1) number and types of self-management support interventions (SMSIs); (2) number of goals set and attained by patients and (3) patient outcomes (glycaemic control, medication adherence and satisfaction). METHODS: Pharmacists (n=109) from 90 community pharmacies in Australia were trained and credentialed to deliver the DMAS. The training focused on developing pharmacists' knowledge and skills in supporting patients' diabetes self-management. RESULTS: A total of 387 patients completed the trial. The mean number of SMSIs per patient was 35 (SD +/-31) and the majority (87%) had at least one documented goal that was fully or partially attained. There were significant health benefits for patients including improved glycaemic control and a reduced risk of non-adherence to medications. Over 90% of DMAS patients reported improvements in their knowledge about diabetes self-management. CONCLUSION: The DMAS provides self management support in the community pharmacy for people with T2DM which may result in improved clinical outcomes. PRACTICE IMPLICATION: Given appropriate training in diabetes care and behavior change strategies, community pharmacists can offer programs which provide self-management support to their patients with T2DM and improve their health outcomes.
机译:目的:通过以下方式评估受过训练的社区药剂师提供糖尿病药物辅助服务(DMAS)的能力和有效性:(1)自我管理支持干预措施(SMSI)的数量和类型; (2)患者设定和达到的目标数量,以及(3)患者预后(血糖控制,药物依从性和满意度)。方法:对来自澳大利亚90家社区药房的药剂师(n = 109)进行了培训,并具有提供DMAS的资格。培训的重点是发展药剂师的知识和技能,以支持患者的糖尿病自我管理。结果:总共387名患者完成了该试验。每位患者的平均SMSI数为35(SD +/- 31),大多数(87%)至少有一个已完全或部分实现的目标。对患者具有显着的健康益处,包括改善血糖控制和减少不依从药物的风险。超过90%的DMAS患者报告他们对糖尿病自我管理的了解有所提高。结论:DMAS在社区药房为T2DM患者提供自我管理支持,这可能会改善临床疗效。实践的意义:接受有关糖尿病护理和行为改变策略的适当培训,社区药师可以提供计划,为患有T2DM的患者提供自我管理支持,并改善他们的健康状况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号